NexImmune, Inc. (NEXI)

NASDAQ: NEXI · IEX Real-Time Price · USD
5.51
-0.17 (-2.99%)
At close: Mar 27, 2024, 4:00 PM
5.65
+0.14 (2.54%)
Pre-market: Mar 28, 2024, 9:10 AM EDT

Total Valuation

NexImmune has a market cap or net worth of $7.18 million. The enterprise value is -$1.27 million.

Market Cap 7.18M
Enterprise Value -1.27M

Important Dates

The next estimated earnings date is Monday, May 13, 2024, after market close.

Earnings Date May 13, 2024
Ex-Dividend Date n/a

Share Statistics

NexImmune has 1.18 million shares outstanding. The number of shares has increased by 7.32% in one year.

Shares Outstanding 1.18M
Shares Change (YoY) +7.32%
Shares Change (QoQ) +0.45%
Owned by Insiders (%) 21.80%
Owned by Institutions (%) 7.97%
Float 753,163

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.87
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.66, with a Debt / Equity ratio of 0.07.

Current Ratio 1.66
Quick Ratio n/a
Debt / Equity 0.07
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -216.30% and return on invested capital (ROIC) is -506.31%.

Return on Equity (ROE) -216.30%
Return on Assets (ROA) -157.00%
Return on Capital (ROIC) -506.31%
Revenue Per Employee n/a
Profits Per Employee -$1.99M
Employee Count 22
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -44.20% in the last 52 weeks. The beta is 1.93, so NexImmune's price volatility has been higher than the market average.

Beta (1Y) 1.93
52-Week Price Change -44.20%
50-Day Moving Average 7.61
200-Day Moving Average 5.88
Relative Strength Index (RSI) 38.47
Average Volume (30 Days) 2,259,316

Short Selling Information

The latest short interest is 35,212, so 2.98% of the outstanding shares have been sold short.

Short Interest 35,212
Short Previous Month 15,758
Short % of Shares Out 2.98%
Short % of Float 4.68%
Short Ratio (days to cover) 0.01

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -44.85M
Pretax Income -43.88M
Net Income -43.88M
EBITDA -42.26M
EBIT -43.88M
Earnings Per Share (EPS) -$42.15
Full Income Statement

Balance Sheet

The company has $9.06 million in cash and $604,638 in debt, giving a net cash position of $8.45 million or $7.14 per share.

Cash & Cash Equivalents 9.06M
Total Debt 604,638
Net Cash 8.45M
Net Cash Per Share $7.14
Equity / Book Value 8.25M
Book Value Per Share 6.98
Working Capital 4.12M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$36.72 million and capital expenditures -$187,655, giving a free cash flow of -$36.91 million.

Operating Cash Flow -36.72M
Capital Expenditures -187,655
Free Cash Flow -36.91M
FCF Per Share -$35.22
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

NexImmune does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -7.32%
Shareholder Yield -7.32%
Earnings Yield -611.39%
FCF Yield -514.29%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on October 19, 2023. It was a reverse split with a ratio of 1:25.

Last Split Date Oct 19, 2023
Split Type Reverse
Split Ratio 1:25

Scores

Altman Z-Score n/a
Piotroski F-Score 2